RetinalGenix Technologies (RTGN) Short-Term Debt repayments (2025 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Short-Term Debt repayments came in at -$30381.0 in Q1 2026, down 187.12% year-on-year from $34873.0 in Q1 2025, and down 187.12% quarter-over-quarter from $34873.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Short-Term Debt repayments (2025 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Short-Term Debt repayments across 2 years of filings, most recently posting -$30381.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | RetinalGenix Technologies | - | - | - | -30,381.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30,381.00 |
| Mar 31, 2026 | -30,381.00 |
| Mar 31, 2025 | 34,873.00 |
| Mar 31, 2025 | 34,873.00 |